| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $66.6M | — | +11.2% |
| Cost of Revenue | $18.2M | — | -1.6% |
| Gross Profit | $48.4M | — | +16.8% |
| R&D Expense | $4.1M | — | -0.9% |
| SG&A Expense | $12.0M | — | +14.9% |
| Operating Income | $17.8M | — | +40.8% |
| Interest Expense | $1.3M | — | +0.8% |
| Pre-tax Income | $19.7M | — | +38.1% |
| Income Tax | $4.0M | — | +23.6% |
| Net Income | $15.7M | — | +42.4% |
| EPS (Basic) | $0.69 | — | +40.8% |
| EPS (Diluted) | $0.68 | — | +41.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $26.9M | -4.9% | +6.0% |
| Accounts Receivable | $35.8M | +6.4% | +1.9% |
| Current Assets | $477.8M | +2.0% | +17.1% |
| Total Assets | $629.5M | +2.2% | +13.2% |
| Current Liabilities | $33.4M | -8.1% | +34.9% |
| Total Liabilities | $222.9M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $15.1M | — | +67.0% |
| Investing Cash Flow | -$13.1M | — | -203.7% |
| Financing Cash Flow | -$3.2M | — | +38.6% |
| +6.9% |
| Stockholders' Equity | $406.6M | +3.3% | +17.0% |